Involvement of the chemokine CCL3 and the purinoceptor p2× 7 in the spinal cord in paclitaxel-induced mechanical allodynia

R Ochi-Ishi, K Nagata, T Inoue… - Molecular …, 2014 - journals.sagepub.com
Background: Paclitaxel is an effective chemotherapeutic agent widely used for the treatment
of solid tumors. The major dose-limiting toxicity of paclitaxel is peripheral neuropathy. The …

[引用][C] Involvement of the Chemokine CCL3 and the Purinoceptor P2× 7 in the Spinal Cord in Paclitaxel-Induced Mechanical Allodynia

R Ochi-Ishi, K Nagata, T Inoue, H Tozaki-Saitoh… - Molecular Pain, 2014 - cir.nii.ac.jp
Involvement of the Chemokine CCL3 and the Purinoceptor P2×7 in the Spinal Cord in
Paclitaxel-Induced Mechanical Allodynia | CiNii Research CiNii 国立情報学研究所 学術情報 …

Involvement of the chemokine CCL3 and the purinoceptor P2X7 in the spinal cord in paclitaxel-induced mechanical allodynia

R Ochi-ishi, K Nagata, T Inoue, H Tozaki-Saitoh… - Molecular …, 2014 - go.gale.com
Involvement of the chemokine CCL3 and the purinoceptor P2X7 in the spinal cord in
paclitaxel-induced mechanical allodynia - Document - Gale OneFile: Health and Medicine …

[HTML][HTML] Involvement of the chemokine CCL3 and the purinoceptor P2X7 in the spinal cord in paclitaxel-induced mechanical allodynia

R Ochi-ishi, K Nagata, T Inoue, H Tozaki-Saitoh… - Molecular …, 2014 - ncbi.nlm.nih.gov
Background Paclitaxel is an effective chemotherapeutic agent widely used for the treatment
of solid tumors. The major dose-limiting toxicity of paclitaxel is peripheral neuropathy. The …

[HTML][HTML] Involvement of the chemokine CCL3 and the purinoceptor P2X7 in the spinal cord in paclitaxel-induced mechanical allodynia

R Ochi-ishi, K Nagata, T Inoue… - Molecular …, 2014 - molecularpain.biomedcentral.com
Paclitaxel is an effective chemotherapeutic agent widely used for the treatment of solid
tumors. The major dose-limiting toxicity of paclitaxel is peripheral neuropathy. The …

[PDF][PDF] Involvement of the chemokine CCL3 and the purinoceptor P2X7 in the spinal cord in paclitaxel-induced mechanical allodynia

R Ochi-ishi, K Nagata, T Inoue, H Tozaki-Saitoh… - 2014 - scienceopen.com
Background: Paclitaxel is an effective chemotherapeutic agent widely used for the treatment
of solid tumors. The major dose-limiting toxicity of paclitaxel is peripheral neuropathy. The …

[HTML][HTML] Involvement of the chemokine CCL3 and the purinoceptor P2X7 in the spinal cord in paclitaxel-induced mechanical allodynia

R Ochi-ishi, K Nagata, T Inoue, H Tozaki-Saitoh… - Molecular Pain, 2014 - Springer
Background Paclitaxel is an effective chemotherapeutic agent widely used for the treatment
of solid tumors. The major dose-limiting toxicity of paclitaxel is peripheral neuropathy. The …

[PDF][PDF] Involvement of the chemokine CCL3 and the purinoceptor P2X7 in the spinal cord in paclitaxel-induced mechanical allodynia

R Ochi-ishi, K Nagata, T Inoue, H Tozaki-Saitoh… - 2014 - cyberleninka.org
Background: Paclitaxel is an effective chemotherapeutic agent widely used for the treatment
of solid tumors. The major dose-limiting toxicity of paclitaxel is peripheral neuropathy. The …

[HTML][HTML] Involvement of the chemokine CCL3 and the purinoceptor P2X7 in the spinal cord in paclitaxel-induced mechanical allodynia.

R Ochi-ishi, K Nagata, T Inoue, H Tozaki-Saitoh… - Molecular …, 2014 - europepmc.org
Background Paclitaxel is an effective chemotherapeutic agent widely used for the treatment
of solid tumors. The major dose-limiting toxicity of paclitaxel is peripheral neuropathy. The …

Involvement of the chemokine CCL3 and the purinoceptor P2X7 in the spinal cord in paclitaxel-induced mechanical allodynia

R Ochi-ishi, K Nagata, T Inoue… - Molecular …, 2014 - search.proquest.com
Background: Paclitaxel is an effective chemotherapeutic agent widely used for the treatment
of solid tumors. The major dose-limiting toxicity of paclitaxel is peripheral neuropathy. The …